Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Sep 20, 2024 | (FY)Sep 20, 2023 | (FY)Sep 20, 2022 | (FY)Sep 20, 2021 | (FY)Sep 20, 2020 | (FY)Sep 20, 2019 | (FY)Sep 20, 2018 | (FY)Sep 20, 2017 | (FY)Sep 20, 2016 | (FY)Sep 20, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -13.61%3.02B | 35.17%3.49B | 128.90%2.58B | -79.28%1.13B | 571.26%5.44B | -148.51%-1.16B | -19.97%2.38B | 0.03%2.98B | -27.52%2.97B | -2.86%4.1B |
Net profit before non-cash adjustment | 36.83%821M | -25.00%600M | -53.35%800M | 18.36%1.72B | 146.18%1.45B | -176.22%-3.14B | 1,779.91%4.12B | -90.55%219M | -19.54%2.32B | 5.30%2.88B |
Total adjustment of non-cash items | -6.28%2.84B | 21.10%3.03B | 109.04%2.5B | -48.69%1.2B | -38.21%2.33B | 303.73%3.77B | -180.86%-1.85B | 121.06%2.29B | -12.58%1.04B | -1.09%1.18B |
-Depreciation and amortization | -8.86%1.4B | 1.39%1.54B | 9.63%1.51B | 14.70%1.38B | 9.16%1.2B | 19.63%1.1B | 1.99%922M | 4.03%904M | 0.93%869M | 27.37%861M |
-Reversal of impairment losses recognized in profit and loss | 0.90%1.58B | 57.52%1.56B | 1,779.66%991M | -263.89%-59M | -98.86%36M | --3.17B | ---- | 4,836.00%1.23B | --25M | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -48.63%94M | 86.73%183M |
-Disposal profit | ---18M | --0 | ---- | ---- | ---- | ---- | ---- | ---15M | ---- | ---- |
-Pension and employee benefit expenses | --0 | ---177M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other non-cash items | -214.15%-121M | 1,614.29%106M | 94.49%-7M | -111.66%-127M | 316.50%1.09B | 81.85%-503M | -1,780.00%-2.77B | 251.06%165M | -66.43%47M | -66.90%140M |
Changes in working capital | -372.59%-638M | 81.20%-135M | 59.69%-718M | -207.22%-1.78B | 193.00%1.66B | -1,666.67%-1.79B | -75.59%114M | 223.22%467M | -1,097.37%-379M | -86.94%38M |
-Change in receivables | 94.41%-20M | -195.87%-358M | 63.44%-121M | 19.46%-331M | 24.59%-411M | -1,551.52%-545M | 0.00%-33M | -140.24%-33M | 179.61%82M | -49.28%-103M |
-Change in inventory | 26.30%-283M | 57.99%-384M | -872.34%-914M | -108.95%-94M | 201.25%1.05B | -386.85%-1.04B | -197.71%-213M | 127.08%218M | 140.85%96M | 65.79%-235M |
-Change in payables | -116.98%-284M | 856.00%1.67B | 112.45%175M | -238.80%-1.41B | 548.23%1.01B | -186.26%-226M | 870.37%262M | 106.84%27M | -483.50%-395M | -89.51%103M |
-Change in accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -159.34%-162M | 320.00%273M |
-Provision for loans, leases and other losses | 95.22%-51M | -850.70%-1.07B | 184.00%142M | 455.56%50M | -59.09%9M | -77.55%22M | -61.57%98M | --255M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 15.94%-58M | 21.59%-69M | 19.27%-88M | -1.87%-109M | -20.22%-107M | -3.49%-89M | 20.37%-86M | 14.96%-108M | 14.77%-127M | 3.87%-149M |
Interest received (cash flow from operating activities) | 1M | 0 | 0 | 0 | 0 | 0 | 1M | 0 | -50.00%1M | 0.00%2M |
Tax refund paid | 24.68%-464M | -41.61%-616M | 20.33%-435M | -27,200.00%-546M | 99.19%-2M | 27.06%-248M | 44.89%-340M | 41.18%-617M | -24.73%-1.05B | 34.86%-841M |
Other operating cash inflow (outflow) | -93.44%8M | -53.08%122M | 26,100.00%260M | -200.00%-1M | 1M | 0 | 14,922.22%2.7B | -5.26%18M | 18.75%19M | -98.08%16M |
Operating cash flow | -14.52%2.5B | 26.22%2.93B | 391.31%2.32B | -91.15%472M | 457.57%5.34B | -132.02%-1.49B | 105.47%4.66B | 24.75%2.27B | -41.94%1.82B | -13.39%3.13B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 36.96%-631M | 42.17%-1B | -465.69%-1.73B | 68.84%-306M | 82.37%-982M | -126.10%-5.57B | -523.80%-2.46B | -252.68%-395M | 85.59%-112M | 35.89%-777M |
Net intangibles purchase and sale | -0.92%-219M | -93.75%-217M | -0.90%-112M | -326.92%-111M | -8.33%-26M | 41.46%-24M | -310.00%-41M | 67.74%-10M | -55.00%-31M | 37.50%-20M |
Net investment product transactions | ---- | ---- | -80.77%250M | 273.33%1.3B | -480.71%-750M | 61.48%197M | 4,166.67%122M | 0.00%-3M | 0.00%-3M | 0.00%-3M |
Net changes in other investments | -79.55%18M | 486.67%88M | 131.91%15M | -159.49%-47M | 111.99%79M | -4,218.75%-659M | -82.42%16M | 1,920.00%91M | -108.93%-5M | 158.33%56M |
Investing cash flow | 26.37%-832M | 28.39%-1.13B | -288.76%-1.58B | 149.79%836M | 72.28%-1.68B | -155.89%-6.06B | -646.69%-2.37B | -109.93%-317M | 79.70%-151M | 44.60%-744M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 41.89%-480M | 49.66%-826M | -258.30%-1.64B | -16.84%-458M | -106.75%-392M | 417.90%5.81B | -8.17%-1.83B | 0.12%-1.69B | -144.72%-1.69B | 50.22%-691M |
Net common stock issuance | -693.29%-1.3B | ---164M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash dividends paid | -104.02%-355M | -4.19%-174M | 8.74%-167M | ---183M | ---- | 0.31%-322M | -3.53%-323M | -6.12%-312M | -2.44%-294M | -4.36%-287M |
Net other fund-raising expenses | 32.96%-301M | 12.65%-449M | 13.03%-514M | -36.49%-591M | -20.28%-433M | -28.11%-360M | -27.73%-281M | -12.24%-220M | -15.98%-196M | -92.05%-169M |
Financing cash flow | -51.08%-2.44B | 30.53%-1.61B | -88.47%-2.32B | -49.33%-1.23B | -116.09%-825M | 310.86%5.13B | -9.46%-2.43B | -1.83%-2.22B | -90.15%-2.18B | 34.49%-1.15B |
Net cash flow | ||||||||||
Beginning cash position | 2.95%6.38B | -20.32%6.2B | 1.00%7.78B | 58.06%7.7B | -33.21%4.87B | -1.87%7.3B | -3.50%7.44B | -6.28%7.71B | 17.76%8.22B | 8.05%6.98B |
Current changes in cash | -516.85%-767M | 111.64%184M | -2,180.26%-1.58B | -97.32%76M | 216.84%2.83B | -1,655.80%-2.42B | 48.89%-138M | 47.47%-270M | -141.45%-514M | 138.00%1.24B |
Cash adjustments other than cash changes | 200.00%1M | ---1M | ---- | 200.00%1M | 0.00%-1M | 0.00%-1M | ---1M | ---- | ---2M | ---- |
End cash Position | -12.00%5.62B | 2.95%6.38B | -20.32%6.2B | 1.00%7.78B | 58.06%7.7B | -33.21%4.87B | -1.87%7.3B | -3.50%7.44B | -6.28%7.71B | 17.76%8.22B |
Free cash flow | -6.85%1.59B | 259.03%1.71B | 765.45%476M | -98.73%55M | 161.06%4.33B | -428.86%-7.09B | 15.67%2.16B | 11.22%1.86B | -28.23%1.68B | -1.56%2.33B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |